Michelle L. Basil

2020

In 2020, Michelle L. Basil earned a total compensation of $2.5M as Executive Vice President, General Counsel at Haemonetics, a 18% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$489,838
Option Awards$274,990
Salary$461,803
Stock Awards$1,298,603
Other$17,209
Total$2,542,443

Basil received $1.3M in stock awards, accounting for 51% of the total pay in 2020.

Basil also received $489.8K in non-equity incentive plan, $275K in option awards, $461.8K in salary and $17.2K in other compensation.

Rankings

In 2020, Michelle L. Basil's compensation ranked 4,471st out of 13,090 executives tracked by ExecPay. In other words, Basil earned more than 65.8% of executives.

ClassificationRankingPercentile
All
4,471
out of 13,090
66th
Division
Manufacturing
1,812
out of 5,620
68th
Major group
Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks
229
out of 799
71st
Industry group
Surgical, Medical, And Dental Instruments And Supplies
128
out of 495
74th
Industry
Surgical and Medical Instruments and Apparatus
82
out of 313
74th

Pay ratio

Michelle L. Basil's Pay$2,542,443
Median Employee's Pay$43,875
Pay Ratio

58

to 1

In 2020, the annual total compensation of Michelle L. Basil was $2,542,443.

The annual total compensation of the median employee at Haemonetics was $43,875.

The ratio of Michelle L. Basil's pay to the pay of median employee was therefore 58 to one.

Source: SEC filing on June 8, 2020.

Basil's colleagues

We found four more compensation records of executives who worked with Michelle L. Basil at Haemonetics in 2020.

2020

Christopher Simon

Haemonetics

Chief Executive Officer

2020

William Burke

Haemonetics

Chief Financial Officer

2020

Josep Llorens

Haemonetics

Senior Vice President, Global Manufacturing and Supply Chain

2020

Jacqueline Scanlan

Haemonetics

Senior Vice President, Global Human Resources

News

You may also like